Quest Partners LLC Buys 2,517 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quest Partners LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 384.9% in the third quarter, HoldingsChannel reports. The firm owned 3,171 shares of the company’s stock after purchasing an additional 2,517 shares during the quarter. Quest Partners LLC’s holdings in HCA Healthcare were worth $1,289,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Capital World Investors increased its stake in shares of HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares during the period. Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. TD Asset Management Inc boosted its holdings in HCA Healthcare by 2.7% in the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after purchasing an additional 19,812 shares during the period. Epoch Investment Partners Inc. boosted its holdings in HCA Healthcare by 16.4% in the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the period. Finally, National Pension Service boosted its holdings in HCA Healthcare by 11.9% in the 3rd quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after purchasing an additional 58,353 shares during the period. 62.73% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $335.11 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $245.03 and a twelve month high of $417.14. The company’s fifty day moving average is $383.10 and its 200 day moving average is $358.30. The stock has a market cap of $84.88 billion, a price-to-earnings ratio of 15.05, a P/E/G ratio of 1.32 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.79%. HCA Healthcare’s payout ratio is 11.85%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Barclays decreased their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. KeyCorp decreased their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. TD Cowen lowered their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Truist Financial lifted their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $385.00.

Read Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.